These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2354709)

  • 1. Norfloxacin use in urinary tract infection by urologists and infectious disease specialists.
    Kunkel MJ; Iannini PB; Landes R; Harrison L; Wells G; Snow R; Schaeffer AJ; Goldstein EJ; Berman S
    Eur Urol; 1990; 17 Suppl 1():30-3. PubMed ID: 2354709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Norfloxacin in the treatment of urinary tract infections in men with and without identifiable urologic complications.
    Corrado ML; Grad C; Sabbaj J
    Am J Med; 1987 Jun; 82(6B):70-4. PubMed ID: 3300314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiclinic study of norfloxacin for treatment of urinary tract infections.
    Schaeffer AJ
    Am J Med; 1987 Jun; 82(6B):53-8. PubMed ID: 3300311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Norfloxacin versus trimethoprim-sulfamethoxazole in the treatment of urinary tract infections.
    Corrado ML; Hesney M; Struble WE; Brown KR; Eng RH; Landes R; Harrison L; Ryan J; Bolding OT
    Eur Urol; 1990; 17 Suppl 1():34-9. PubMed ID: 2191867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of the efficacy of oral norfloxacin in pyelonephritis and nosocomial urinary tract infection.
    Corrado ML; Roylance PJ; Struble WE; Lancaster MS
    Eur Urol; 1990; 17 Suppl 1():24-9. PubMed ID: 2191866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral norfloxacin versus parenteral treatment of nosocomial urinary tract infection.
    Cox CE; McCabe RE; Grad C
    Am J Med; 1987 Jun; 82(6B):59-64. PubMed ID: 3300312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of norfloxacin in complicated and recurrent urinary tract infections.
    Schaeffer AJ
    Eur Urol; 1990; 17 Suppl 1():19-23. PubMed ID: 2191865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Norfloxacin in the treatment of complicated and uncomplicated urinary tract infections. A comparative multicenter trial.
    Goldstein EJ; Alpert ML; Najem A; Eng RH; Ginsburg BP; Kahn RM; Cherubin CE
    Am J Med; 1987 Jun; 82(6B):65-9. PubMed ID: 3300313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fleroxacin versus norfloxacin for oral treatment of serious urinary tract infections.
    Childs SJ
    Am J Med; 1993 Mar; 94(3A):105S-107S. PubMed ID: 8452164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fleroxacin versus norfloxacin in the treatment of urinary tract infections: a multicenter, double-blind, prospective, randomized, comparative study.
    Pummer K
    Am J Med; 1993 Mar; 94(3A):108S-113S. PubMed ID: 8452165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of norfloxacin in lower urinary tract infections.
    Miano L; Goldoni S; Tubaro A; Paradiso Galatioto G; Gandolfi P
    Eur Urol; 1990; 17 Suppl 1():13-8. PubMed ID: 2191864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-dose ciprofloxacin versus 3 days of norfloxacin in uncomplicated urinary tract infections in women.
    Auquer F; Cordón F; Gorina E; Caballero JC; Adalid C; Batlle J;
    Clin Microbiol Infect; 2002 Jan; 8(1):50-4. PubMed ID: 11906502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of norfloxacin vs. ciprofloxacin in complicated urinary tract infection.
    Schaeffer AJ; Anderson RU
    Urology; 1992 Nov; 40(5):446-9. PubMed ID: 1441044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and tolerability of short course co-trimoxazole, norfloxacin and levofloxacin in bacteriological cure of uncomplicated urinary tract infection in outpatient setting. An open label, parallel group, randomized controlled trial.
    Vachhani AV; Barvaliya M; Naik V; Jha P; Tripathi C
    Infez Med; 2015 Jun; 23(2):155-60. PubMed ID: 26110296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Norfloxacin versus parenteral therapy in the treatment of complicated urinary tract infections and resistant organisms.
    Cherubin C; Stilwell S
    Scand J Infect Dis Suppl; 1986; 48():32-7. PubMed ID: 3535053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical studies of norfloxacin in urinary tract infections].
    Matsuura T; Kurita T
    Hinyokika Kiyo; 1985 Nov; 31(11):2085-9. PubMed ID: 4091145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coordinated multicenter study of norfloxacin versus trimethoprim-sulfamethoxazole treatment of symptomatic urinary tract infections. The Urinary Tract Infection Study Group.
    J Infect Dis; 1987 Feb; 155(2):170-7. PubMed ID: 2879872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Norfloxacin versus pipemidic acid in complicated urinary tract infections due to susceptible pathogens: a comparative clinical trial.
    Del Favero A; Frongillo RF; Menichetti F; Boldrini F; Guerciolini R; Pauluzzi S
    Chemioterapia; 1986 Apr; 5(2):88-91. PubMed ID: 3518966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-dose compared with 3-day norfloxacin treatment of uncomplicated urinary tract infection in women. Canadian Infectious Diseases Society Clinical Trials Study Group.
    Saginur R; Nicolle LE
    Arch Intern Med; 1992 Jun; 152(6):1233-7. PubMed ID: 1599352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Norfloxacin versus nalidixic acid in the treatment of urinary tract infections.
    Karachalios GN; Georgiopoulos AN
    Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):317-9. PubMed ID: 3623736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.